137 related articles for article (PubMed ID: 27511884)
1. CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma.
Prakash H; Nadella V; Singh S; Schmitz-Winnenthal H
Sci Rep; 2016 Aug; 6():31490. PubMed ID: 27511884
[TBL] [Abstract][Full Text] [Related]
2. Palmitic acid combined with γ-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages' polarization via the TLR4 pathway.
Zhang YY; Li J; Li F; Xue S; Xu QY; Zhang YQ; Feng L
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7053-7067. PubMed ID: 36862159
[TBL] [Abstract][Full Text] [Related]
3. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.
Grimmig T; Moench R; Kreckel J; Haack S; Rueckert F; Rehder R; Tripathi S; Ribas C; Chandraker A; Germer CT; Gasser M; Waaga-Gasser AM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941651
[TBL] [Abstract][Full Text] [Related]
4. CD14 is a key organizer of microglial responses to CNS infection and injury.
Janova H; Böttcher C; Holtman IR; Regen T; van Rossum D; Götz A; Ernst AS; Fritsche C; Gertig U; Saiepour N; Gronke K; Wrzos C; Ribes S; Rolfes S; Weinstein J; Ehrenreich H; Pukrop T; Kopatz J; Stadelmann C; Salinas-Riester G; Weber MS; Prinz M; Brück W; Eggen BJ; Boddeke HW; Priller J; Hanisch UK
Glia; 2016 Apr; 64(4):635-49. PubMed ID: 26683584
[TBL] [Abstract][Full Text] [Related]
5. Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide.
Kuo WT; Lee TC; Yu LC
Cancer Res; 2016 Aug; 76(16):4684-95. PubMed ID: 27328732
[TBL] [Abstract][Full Text] [Related]
6. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
7. Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages.
Wang B; Zheng X; Liu J; Zhang Z; Qiu C; Yang L; Zhang L; Zhang Q; Gao H; Wang X
J Pharmacol Sci; 2018 Jul; 137(3):290-298. PubMed ID: 30098910
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 signaling promotes tumor growth.
Lee CH; Wu CL; Shiau AL
J Immunother; 2010 Jan; 33(1):73-82. PubMed ID: 19952954
[TBL] [Abstract][Full Text] [Related]
9. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ.
Okuyama H; Tominaga A; Fukuoka S; Taguchi T; Kusumoto Y; Ono S
Oncol Rep; 2017 Feb; 37(2):684-694. PubMed ID: 28075473
[TBL] [Abstract][Full Text] [Related]
10. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages.
El Chartouni C; Rehli M
Immunobiology; 2010; 215(9-10):780-7. PubMed ID: 20692533
[TBL] [Abstract][Full Text] [Related]
12. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
[TBL] [Abstract][Full Text] [Related]
13. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
14. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer.
Farajzadeh Valilou S; Keshavarz-Fathi M; Silvestris N; Argentiero A; Rezaei N
Cytokine Growth Factor Rev; 2018 Feb; 39():46-61. PubMed ID: 29373197
[TBL] [Abstract][Full Text] [Related]
15. The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway.
Ma X; Wu D; Zhou S; Wan F; Liu H; Xu X; Xu X; Zhao Y; Tang M
Oncol Rep; 2016 Jan; 35(1):189-96. PubMed ID: 26531138
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers.
Huang Z; Yang Y; Jiang Y; Shao J; Sun X; Chen J; Dong L; Zhang J
Biomaterials; 2013 Jan; 34(3):746-55. PubMed ID: 23107297
[TBL] [Abstract][Full Text] [Related]
17. Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.
Zhu Y; Herndon JM; Sojka DK; Kim KW; Knolhoff BL; Zuo C; Cullinan DR; Luo J; Bearden AR; Lavine KJ; Yokoyama WM; Hawkins WG; Fields RC; Randolph GJ; DeNardo DG
Immunity; 2017 Aug; 47(2):323-338.e6. PubMed ID: 28813661
[TBL] [Abstract][Full Text] [Related]
18. Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.
Cullis J; Siolas D; Avanzi A; Barui S; Maitra A; Bar-Sagi D
Cancer Immunol Res; 2017 Mar; 5(3):182-190. PubMed ID: 28108630
[TBL] [Abstract][Full Text] [Related]
19. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.
Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F
Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
